Equity Capital Markets

Company · CIK 1593899

Atea Pharmaceuticals, Inc.

CIK1593899 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inMA
Business addressMA
ListedAVIR (Nasdaq)
First annual or quarterly report2020-12-10

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-283073
ShelfEffective
 2024-11-072024-11-192
333-261344
ShelfEffective
 2021-11-242022-05-122
333-249404
IPOFinal prospectus
 2020-10-092020-10-305

Filings

10
FiledFilingRegistrationAccession
2024-11-19EFFECTDeclared effective 333-2830739999999995-24-003516
2024-11-07S-3Shelf registered 333-2830730001193125-24-253272
2022-05-12EFFECTDeclared effective 333-2613449999999995-22-001427
2021-11-24S-3ASRShelf registered 333-2613440001193125-21-340320
2020-10-30424B4Final prospectus 333-2494040001193125-20-282645
2020-10-29EFFECTDeclared effective 333-2494049999999995-20-003030
2020-10-26S-1/AAmendment 333-2494040001193125-20-275997
2020-10-23S-1/AAmendment 333-2494040001193125-20-274635
2020-10-09S-1Registration filed 333-2494040001193125-20-267199
2020-06-19DRSDraft made public 377-032310000950123-20-006302

All filings of this company · CSV